Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek

WALTHAM, Mass., September 05, 2007 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. , the world leader in serving science, has acquired the instrument sales business of Davis Inotek Instruments, LLC. The acquired business will be branded Davis Instruments and excludes its related calibration services. Davis Instruments is a leading provider of test, measurement and process control instruments, serving customers in a wide range of industries through its extensive catalog and e-commerce sales channels. The instrument sales business had revenues of approximately $30 million in 2006.

Davis Instruments will become part of Thermo Fisher's Cole-Parmer customer channel, a specialty catalog brand that provides technical instruments, equipment and supplies to industrial, pharmaceutical, academic and government customers around the world.

"Our Cole-Parmer channel is a well-known resource for the specialty instruments and consumables that our customers need for their scientific research or industrial process applications," commented Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific. "The addition of Davis Instruments is a perfect complement to the Cole-Parmer channel, and will strengthen our ability to meet our customers' needs through a range of convenient purchasing options."

About Thermo Fisher Scientific

Thermo Fisher Scientific is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com .

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward- looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2007, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission and available in the "Investors" section of our Website under the heading "SEC Filings." We also may make forward-looking statements about the benefits of the merger of Thermo Electron and Fisher Scientific, including statements about future financial and operating results, the new company's plans, objectives, expectations and intentions and other statements that are not historical facts. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the risk that the businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; use and protection of intellectual property; dependence on customers' capital spending policies and government funding policies; realization of potential future savings from new productivity initiatives; general worldwide economic conditions and related uncertainties; the effect of changes in governmental regulations; the effect of exchange rate fluctuations on international operations; the effect of laws and regulations governing government contracts; the effect of competing with certain of our customers and suppliers; and the effect of rapid changes in the healthcare industry. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

    Media Contact Information:           Investor Contact Information:

    Lori Gorski                          Ken Apicerno

    Phone:  781-622-1242                 Phone:  781-622-1111

    E-mail:  E-mail: 

    Website:  www.thermofisher.com

CONTACT: Media, Lori Gorski, +1-781-622-1242, , or Investors, Ken Apicerno, +1-781-622-1111, , both of Thermo Fisher Scientific Inc. lori.gorski@thermofisher.com ken.apicerno@thermofisher.com

Web site: http://www.thermofisher.com//

Company News On-Call: http://www.prnewswire.com/comp/877850.html/

Ticker Symbol: (NYSE:TMO)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Latest Pharma Industry News...

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals